These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
92 related items for PubMed ID: 39440
1. Autoantibodies in human sera after vaccination with inactivated influenza vaccine. Loza-Tulimowska M, Semkow R, Michalak T, Wilczyński J. Acta Virol; 1979 Mar; 23(2):159-61. PubMed ID: 39440 [Abstract] [Full Text] [Related]
2. Autoantibodies in sera of rabbits immunized with influenza virus. Loza-Tulimowska M, Michalak T, Semkow R, Nowosławski A. Acta Virol; 1977 Nov; 21(6):495-8. PubMed ID: 23669 [Abstract] [Full Text] [Related]
3. E-rosette forming cells and humoral antibody titres in humans after vaccination with three different inactivated influenza virus vaccines A/USSR/92/77 (H1N1). Schmidt S, Süss J, Oehring H, Schmidt J. Acta Virol; 1982 Dec; 26(6):466-73. PubMed ID: 6132540 [Abstract] [Full Text] [Related]
4. [Sensitivity of the ELISA immunoenzyme test for detecting the antibody response of persons vaccinated with an inactivated influenza vaccine]. Proietti E, Rapicetta M, Morace G, Arangio-Ruiz G, Macchia T, Mancini G. Ann Ist Super Sanita; 1982 Dec; 18(3):521-4. PubMed ID: 7187838 [No Abstract] [Full Text] [Related]
5. Preliminary results of oral influenza vaccination with live attenuated viruses. DeBarbieri A, Crovari P, Cuneo-Crovari P, Badolati G, Giacometti G. Dev Biol Stand; 1976 Dec; 33():213-9. PubMed ID: 782972 [Abstract] [Full Text] [Related]
7. [Use of the elution inhibition reaction for detecting antineuraminidase antibodies in the sera of persons inoculated with inactivated influenza vaccine]. Briantseva EA. Tr Inst Im Pastera; 1982 Dec; 59():59-62. PubMed ID: 6764988 [No Abstract] [Full Text] [Related]
8. Use of an inhibitor-resistant live attenuated influenza vaccine in normal and asthmatic adults. Warshauer DM, Minor TE, Inhorn SL, Reed CE, Dick EC. Dev Biol Stand; 1976 Dec; 33():184-90. PubMed ID: 782967 [Abstract] [Full Text] [Related]
9. [Effectiveness of inactivated vaccines against influenza]. Fridman EA, Peradze TV. Tr Inst Im Pastera; 1982 Dec; 58():84-94. PubMed ID: 6764983 [No Abstract] [Full Text] [Related]
10. Characteristic of humoral response of elderly to inactivated influenza vaccine. Siennicka J. Arch Immunol Ther Exp (Warsz); 1996 Dec; 44(5-6):389-94. PubMed ID: 9017157 [Abstract] [Full Text] [Related]
11. Characteristics of cell-mediated immunity after oral administration of a live influenza vaccine. Unanov SS, Yuminova NV, Akopova II. Acta Virol; 1982 Dec; 26(6):474-80. PubMed ID: 6132541 [Abstract] [Full Text] [Related]
12. An MF59-adjuvanted inactivated influenza vaccine containing A/Panama/1999 (H3N2) induced broader serological protection against heterovariant influenza virus strain A/Fujian/2002 than a subunit and a split influenza vaccine. Del Giudice G, Hilbert AK, Bugarini R, Minutello A, Popova O, Toneatto D, Schoendorf I, Borkowski A, Rappuoli R, Podda A. Vaccine; 2006 Apr 12; 24(16):3063-5. PubMed ID: 16464520 [Abstract] [Full Text] [Related]
13. Shedding and immunogenicity of live attenuated influenza vaccine virus in subjects 5-49 years of age. Block SL, Yogev R, Hayden FG, Ambrose CS, Zeng W, Walker RE. Vaccine; 2008 Sep 08; 26(38):4940-6. PubMed ID: 18662737 [Abstract] [Full Text] [Related]
14. Intranasal influenzavirus vaccine in children. Edwards KM, Dupont WD. N Engl J Med; 1998 Sep 24; 339(13):922; author reply 922-3. PubMed ID: 9750091 [No Abstract] [Full Text] [Related]
15. The specificity of serum antibodies to the haemagglutinin of influenza B viruses induced by vaccination. Creţescu L, Ioniţă E, Niculescu IT, Coban V, Bogdan C. Arch Roum Pathol Exp Microbiol; 1987 Sep 24; 46(1):27-33. PubMed ID: 3324992 [No Abstract] [Full Text] [Related]
16. Immunization against influenza: comparison of various topical and parenteral regimens containing inactivated and/or live attenuated vaccines in healthy adults. Keitel WA, Cate TR, Nino D, Huggins LL, Six HR, Quarles JM, Couch RB. J Infect Dis; 2001 Jan 15; 183(2):329-332. PubMed ID: 11110645 [Abstract] [Full Text] [Related]
17. [Results of a 3-year survey of persons inoculated with inactivated inflenza vaccine (IIV). II. The immunological effectiveness of IIV and its comparison with the epidemiological]. Mukhina LP, Kozlova NA, Rykushin IuP, Bichurina MA, Polzik TP. Tr Inst Im Pastera; 1979 Jan 15; 52():71-5. PubMed ID: 162089 [No Abstract] [Full Text] [Related]
19. [Inactivated influenza vaccine (H1N1, H3N2, H3N1) - antibody response and protective effect in the influenza epidemic H1N1 in 1979 (author's transl)]. Bruj J, Skocil V, Farník J, Hronovský F, Síp J. Cesk Epidemiol Mikrobiol Imunol; 1981 Sep 15; 30(5):287-93. PubMed ID: 6456837 [No Abstract] [Full Text] [Related]
20. Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adults. King JC, Treanor J, Fast PE, Wolff M, Yan L, Iacuzio D, Readmond B, O'Brien D, Mallon K, Highsmith WE, Lambert JS, Belshe RB. J Infect Dis; 2000 Feb 15; 181(2):725-8. PubMed ID: 10669363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]